This inventor holds 267 USPTO granted patents and 7 published patent applications, primarily in Signal Peptide Proteins (CPC class 4353201). Top assignees: Incyte Pharmaceuticals, Inc., Incyte Genomics, Inc., Incyte Corporation. Active years: 1997-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Mountain, CA (US) (1999 - 2001)
- Mountain View, CA (US) (1997 - 2018)
Company Filing History:
186 out of 576 
47 out of 163 
30 out of 687 
Years Active: 1997-2024
Areas of Expertise:
Title: Olga Bandman: A Pioneer in Secreted Protein Research
Introduction:
Olga Bandman, a prominent inventor based in Mountain View, California, has made significant contributions to the field of secreted proteins. With an impressive portfolio of 266 patents, Bandman has played a pivotal role in advancing our understanding of these essential components of human biology. Let's delve into Bandman's latest patents, career highlights, notable collaborations, and the impact of her work in the field.
Latest Patents:
Bandman's recent patents revolve around the discovery and characterization of human secreted proteins (SECP) and human signal peptide-containing proteins (HSPP). These inventions not only identify and encode these key proteins but also provide valuable insights into their expression, detection, and potential for therapeutic applications in disorders associated with aberrant expression.
One of her latest patents focuses on the invention of human secreted proteins (SECP). This breakthrough invention offers polynucleotides, expression vectors, host cells, antibodies, agonists, and antagonists associated with SECP. Additionally, it provides novel methods for diagnosing, treating, or preventing disorders resulting from the dysregulation of SECP expression.
Another notable invention by Bandman involves identifying and encoding human signal peptide-containing proteins (HSPP). Similar to her SECP patent, this invention opens up avenues for diagnosing, treating, or preventing disorders associated with the expression of HSPP. Furthermore, it encompasses polynucleotides, expression vectors, host cells, antibodies, agonists, and antagonists associated with HSPP.
Career Highlights:
Olga Bandman's remarkable career has seen her make significant contributions to various prominent organizations in the pharmaceutical and genomics industries. Bandman has contributed to the success of Incyte Pharmaceuticals, Inc., and Incyte Genomics, Inc., where her expertise and innovative thinking have played a pivotal role in advancing our understanding of secreted proteins.
Collaborations:
Throughout her career, Bandman has had the privilege of collaborating with notable individuals in the field. Her collaborations with experts like Neil C Corley and Preeti Lal have fostered an environment of innovation, allowing for the exchange of groundbreaking ideas and the development of transformative inventions.
Conclusion:
Olga Bandman's unwavering dedication to secreted protein research has made her a force to be reckoned with in the scientific community. Her remarkable portfolio of 266 patents, including the recent inventions related to human secreted proteins (SECP) and human signal peptide-containing proteins (HSPP), showcases her pioneering contributions and commitment to advancing human health and biotechnology. As we eagerly await further discoveries from Bandman, her work undoubtedly continues to shape the future of secreted protein research and its potential therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile